Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis

Elizabeth M. Cameron, Sade Spencer, Jonathan Lazarini, Christopher T. Harp, E. Sally Ward, Mark Burgoon, Gregory P. Owens, Michael K. Racke, Jeffrey L. Bennett, Elliot M. Frohman, Nancy L. Monson

Research output: Contribution to journalArticle

34 Scopus citations

Abstract

We identified a unique antibody gene mutation pattern (i.e. "signature") in cerebrospinal fluid (CSF) B cells from multiple sclerosis (MS) patients not present in control populations. Prevalence of the signature in CSF B cells of patients at risk to develop MS predicted conversion to MS with 91% accuracy in a small cohort of clinically isolated syndrome patients. If confirmed, signature prevalence would be a novel genetic diagnostic tool candidate for patients with early demyelinating disease of the central nervous system.

Original languageEnglish (US)
Pages (from-to)123-130
Number of pages8
JournalJournal of Neuroimmunology
Volume213
Issue number1-2
DOIs
StatePublished - Aug 18 2009
Externally publishedYes

Keywords

  • Antibodies
  • B lymphocytes
  • Gene rearrangement
  • Multiple sclerosis
  • Mutational signature

Fingerprint Dive into the research topics of 'Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis'. Together they form a unique fingerprint.

  • Cite this

    Cameron, E. M., Spencer, S., Lazarini, J., Harp, C. T., Ward, E. S., Burgoon, M., Owens, G. P., Racke, M. K., Bennett, J. L., Frohman, E. M., & Monson, N. L. (2009). Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis. Journal of Neuroimmunology, 213(1-2), 123-130. https://doi.org/10.1016/j.jneuroim.2009.05.014